
    
      To compare long term disease modifiying and symptomatic effects at the Baseline visit and
      after 24 months of treatment in patients treated with CHONDROITIN SULPHATE 1200 mg daily vs.
      patients treated with CELECOXIB 200 mg daily.
    
  